AtriCure, Inc. (ATRC)
Makes surgical devices that burn away abnormal heart tissue and manage cardiac arrhythmias.
$38.22+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+11.1%
The outlook
AtriCure trades at $38.22, sitting well above its 50- and 200-day moving averages in the upper portion of its 52-week range. Analyst consensus leans Buy, with an average price target around 23% above the current level. The stock carries a notably elevated trailing P/E ratio of 182, reflecting investor expectations for future growth.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range72% of the way from its 52-week low to high
Price targetAvg target +23% vs current price
Analyst price target
~12-month · 8 analysts$47.00average target+23.0% vs now
Now $38.22
Low $36.00High $55.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.94B
52-wk high
$43.18
52-wk low
$25.36
50-day avg
$30.14
200-day avg
$33.06
Trailing P/E
182.0